Allergan Pharmaceutical Development Cent Er India Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2007.
2007 Bangalore, Karnataka, India Amalgamated
Last Updated:
Access Report
About Allergan Pharmaceutical Development Cent Er India Private Limited

Allergan Pharmaceutical Development Cent Er India Private Limited, a amalgamated private limited company, was established on 19 July 2007 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U73100KA2007PTC043406. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.63 Cr.

Its leadership includes Fidela Llorca Moreno (Director), Raman Pillai Raghu Kumar (Director), Avalur Gopalaratnam Muralikrishnan (Director). Past directors included Thim Engel, Raman Vitthal Shetty, Hans Joachim Lanz. Its latest AGM occurred on 15 July 2011, with the balance sheet filed on 31 March 2011. It is based at No.37,Brahmanandacourt,Groundfloor(Easternwing),Lalbaghroad,, Bangalore, Karnataka, 560027.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2007PTC043406

  • Registration Number

    043406

  • Incorporation Date

    19 July 2007

  • Authorized Capital

    ₹1.75 Cr

  • Paid-Up Capital

    ₹1.63 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 1.75 Cr
  • Paid Up Capital ₹ 1.63 Cr
  • Company Age 18 Year, 11 Months
  • Last Filing with ROC 31 Mar 2011
Company report

Allergan Pharmaceutical Development Cent Er India Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Allergan Pharmaceutical Development Cent Er India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Allergan Pharmaceutical Development Cent Er India Private Limited?
Current Directors
Name Designation Appointment Date Status
Fidela Llorca Moreno Director 28 Jan 2009 Current
Raman Pillai Raghu Kumar Director 29 Jan 2008 Current
Avalur Gopalaratnam Muralikrishnan Director 19 Jul 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 04 Aug 2008 Past
Pramod Abcsdd Director 23 Dec 2009 Past
Pramod Abcsdd Additional Director 26 Sep 2008 Past
Pramod Abcsdd Additional Director 23 Sep 2009 Past
Pramod Abcsdd Director 28 Dec 2007 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Allergan Pharmaceutical Development Cent Er India.

Enhance accessibility to Allergan Pharmaceutical Development Cent Er India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Allergan Pharmaceutical Development Cent Er India revenue growth over time
Allergan Pharmaceutical Development Cent Er India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Allergan Pharmaceutical Development Cent Er India?

Unlock access to Allergan Pharmaceutical Development Cent Er India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Allergan Pharmaceutical Development Cent Er India?

Unlock and access historical data on people associated with Allergan Pharmaceutical Development Cent Er India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Allergan Pharmaceutical Development Cent Er India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allergan Pharmaceutical Development Cent Er India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Allergan Pharmaceutical Development Cent Er India
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Allergan Pharmaceutical Development Cent Er India Private Limited last Annual general meeting of members was held on 15 Jul 2011 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Allergan Pharmaceutical Development Cent Er India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Bangalore. was completed.

  • Director Appointment

    The activity Fidela Llorca Moreno was appointed as a Director was appointed as a Director on 28 Jan 2009 & has been associated with this company since 17 years 5 months . was completed.

  • Director Appointment

    Progress on Raman Pillai Raghu Kumar was appointed as a Director was appointed as a Director on 29 Jan 2008 & has been associated with this company since 18 years 5 months . was documented.

  • Director Appointment

    The activity Avalur Gopalaratnam Muralikrishnan was appointed as a Director was appointed as a Director on 19 Jul 2007 & has been associated with this company since 18 years 11 months . was completed.

  • Company Incorporation

    Allergan Pharmaceutical Development Cent Er India Private Limited was registered on 19 Jul 2007 with Roc Bangalore & aged 18 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Allergan Pharmaceutical Development Cent Er India Private Limited?

The CIN of Allergan Pharmaceutical Development Cent Er India Private Limited is U73100KA2007PTC043406.

Where is Allergan Pharmaceutical Development Cent Er India Private Limited headquartered?

Allergan Pharmaceutical Development Cent Er India Private Limited is headquartered at No.37,Brahmanandacourt,Groundfloor(Easternwing),Lalbaghroad,, Bangalore, Karnataka, 560027.

When was Allergan Pharmaceutical Development Cent Er India Private Limited incorporated?

Allergan Pharmaceutical Development Cent Er India Private Limited was incorporated on 19 July 2007.

Who are the current directors of Allergan Pharmaceutical Development Cent Er India Private Limited?

The current directors of Allergan Pharmaceutical Development Cent Er India Private Limited are

What is the primary industry of Allergan Pharmaceutical Development Cent Er India Private Limited?

The primary industry of Allergan Pharmaceutical Development Cent Er India Private Limited is Pharma.

Is Allergan Pharmaceutical Development Cent Er India Private Limited a listed company?

Allergan Pharmaceutical Development Cent Er India Private Limited is unlisted.

What is the capital structure of Allergan Pharmaceutical Development Cent Er India Private Limited?

The authorized capital of Allergan Pharmaceutical Development Cent Er India Private Limited is ₹1.75 Cr, and the paid-up capital is ₹1.63 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available